REG-BARCLAYS PLC FORM 8.3 - WILLIS TOWERS WATSON PLC
18/12/2020 15:50
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201218:nBwTkPpJa&default-theme=true
FORM 8.3 - WILLIS TOWERS WATSON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 17 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,029,842 2.35% 688,114 0.53%
(2) Derivatives (other than options):
365,705 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,395,547 2.63% 1,427,119 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 2 212.7775 USD
Purchase 4 212.4400 USD
Purchase 7 214.0385 USD
Purchase 7 212.4950 USD
Purchase 8 212.4637 USD
Purchase 9 212.4700 USD
Purchase 11 212.7463 USD
Purchase 17 212.9705 USD
Purchase 21 213.2042 USD
Purchase 23 213.9026 USD
Purchase 24 212.8291 USD
Purchase 26 213.3107 USD
Purchase 31 212.4009 USD
Purchase 35 212.9362 USD
Purchase 38 212.9918 USD
Purchase 40 212.2435 USD
Purchase 42 213.5954 USD
Purchase 42 213.1361 USD
Purchase 42 212.6300 USD
Purchase 44 213.0545 USD
Purchase 52 213.4636 USD
Purchase 66 213.2251 USD
Purchase 95 212.6400 USD
Purchase 96 213.3464 USD
Purchase 100 213.0000 USD
Purchase 100 212.9200 USD
Purchase 100 214.4000 USD
Purchase 100 212.9500 USD
Purchase 158 211.8200 USD
Purchase 266 212.3024 USD
Purchase 300 212.9400 USD
Purchase 300 212.9366 USD
Purchase 437 212.3238 USD
Purchase 546 212.8404 USD
Purchase 804 212.6930 USD
Purchase 1,533 212.8891 USD
Purchase 2,161 212.2520 USD
Purchase 2,396 213.0384 USD
Purchase 3,349 212.9168 USD
Purchase 3,536 213.0653 USD
Purchase 4,647 213.2841 USD
Purchase 6,224 213.6525 USD
Purchase 10,998 213.6500 USD
Purchase 13,731 212.7370 USD
Purchase 15,160 212.6085 USD
Purchase 23,222 212.2300 USD
Purchase 24,751 213.0915 USD
Purchase 35,876 212.9808 USD
Sale 7 212.4950 USD
Sale 42 213.5955 USD
Sale 67 212.0614 USD
Sale 81 212.9380 USD
Sale 100 212.2400 USD
Sale 100 214.4000 USD
Sale 100 212.7100 USD
Sale 100 213.7900 USD
Sale 101 212.9132 USD
Sale 104 213.9451 USD
Sale 159 211.8262 USD
Sale 198 213.0724 USD
Sale 304 213.2800 USD
Sale 402 213.4646 USD
Sale 466 213.3964 USD
Sale 621 213.0209 USD
Sale 652 213.0373 USD
Sale 669 213.4418 USD
Sale 700 212.8639 USD
Sale 1,797 212.8595 USD
Sale 1,900 213.1997 USD
Sale 1,968 212.9660 USD
Sale 2,100 212.9428 USD
Sale 2,265 213.1381 USD
Sale 2,382 212.3342 USD
Sale 2,609 212.4099 USD
Sale 2,746 212.9543 USD
Sale 2,900 212.8544 USD
Sale 2,947 212.8540 USD
Sale 3,000 213.0343 USD
Sale 3,446 212.9283 USD
Sale 3,867 213.0024 USD
Sale 4,295 213.4291 USD
Sale 4,700 212.9171 USD
Sale 5,141 213.5995 USD
Sale 5,215 213.1185 USD
Sale 5,455 213.6956 USD
Sale 7,204 213.0574 USD
Sale 10,746 212.2302 USD
Sale 10,998 213.6500 USD
Sale 11,995 212.2300 USD
Sale 12,033 212.8372 USD
Sale 14,385 212.6467 USD
Sale 20,000 212.7883 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 18 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201218005482/en/
(https://www.businesswire.com/news/home/20201218005482/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
Announcement